ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 191 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $520,000 | -54.3% | 11,232 | -75.9% | 0.01% | -58.3% |
| Q1 2019 | $1,138,000 | +73.7% | 46,658 | +1.4% | 0.01% | +50.0% |
| Q4 2018 | $655,000 | +25.2% | 45,995 | +33.7% | 0.01% | +33.3% |
| Q3 2018 | $523,000 | -70.7% | 34,402 | -67.6% | 0.01% | -75.0% |
| Q2 2018 | $1,782,000 | +1.9% | 106,211 | -0.9% | 0.02% | -14.3% |
| Q1 2018 | $1,748,000 | +388.3% | 107,126 | +268.2% | 0.03% | +300.0% |
| Q3 2017 | $358,000 | +33.1% | 29,092 | -3.3% | 0.01% | 0.0% |
| Q1 2017 | $269,000 | -47.3% | 30,100 | -48.1% | 0.01% | -66.7% |
| Q4 2016 | $510,000 | +146.4% | 58,000 | -0.2% | 0.02% | +61.5% |
| Q2 2016 | $207,000 | -46.9% | 58,100 | -37.2% | 0.01% | -69.8% |
| Q4 2015 | $390,000 | – | 92,500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
| KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
| Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
| QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
| APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
| FBR & Co. | 113,500 | $706,000 | 1.07% |
| Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
| Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
| Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |